CN105025974A - 包含硅基载体粒子的药物递送装置 - Google Patents

包含硅基载体粒子的药物递送装置 Download PDF

Info

Publication number
CN105025974A
CN105025974A CN201480012001.6A CN201480012001A CN105025974A CN 105025974 A CN105025974 A CN 105025974A CN 201480012001 A CN201480012001 A CN 201480012001A CN 105025974 A CN105025974 A CN 105025974A
Authority
CN
China
Prior art keywords
component
pipe
carrier material
benefit materials
devices according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480012001.6A
Other languages
English (en)
Chinese (zh)
Inventor
L·T·坎汉
H·郭
M·纳扎罗
C·巴奈特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psimedica Ltd
Eyepoint Pharmaceuticals US Inc
Original Assignee
Psimedica Ltd
Psivida US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimedica Ltd, Psivida US Inc filed Critical Psimedica Ltd
Publication of CN105025974A publication Critical patent/CN105025974A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B29/00—Packaging of materials presenting special problems
    • B65B29/02—Packaging of substances, e.g. tea, which are intended to be infused in the package
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
    • B65B55/06—Sterilising wrappers or receptacles prior to, or during, packaging by heat
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B55/00—Preserving, protecting or purifying packages or package contents in association with packaging
    • B65B55/02—Sterilising, e.g. of complete packages
    • B65B55/04—Sterilising wrappers or receptacles prior to, or during, packaging
    • B65B55/08—Sterilising wrappers or receptacles prior to, or during, packaging by irradiation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B7/00—Closing containers or receptacles after filling
    • B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
    • B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201480012001.6A 2013-03-12 2014-03-12 包含硅基载体粒子的药物递送装置 Pending CN105025974A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361778111P 2013-03-12 2013-03-12
US61/778,111 2013-03-12
PCT/US2014/024362 WO2014165097A1 (en) 2013-03-12 2014-03-12 Drug delivery device comprising silicon-based carrier particles

Publications (1)

Publication Number Publication Date
CN105025974A true CN105025974A (zh) 2015-11-04

Family

ID=51659062

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480012001.6A Pending CN105025974A (zh) 2013-03-12 2014-03-12 包含硅基载体粒子的药物递送装置

Country Status (9)

Country Link
US (1) US20140309610A1 (enExample)
EP (1) EP2968882B1 (enExample)
JP (1) JP6568513B2 (enExample)
CN (1) CN105025974A (enExample)
AU (1) AU2014248707B2 (enExample)
CA (1) CA2904204A1 (enExample)
HK (1) HK1216864A1 (enExample)
RU (1) RU2695536C2 (enExample)
WO (1) WO2014165097A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112137984A (zh) * 2020-10-30 2020-12-29 四川制药制剂有限公司 头孢克洛胶囊及其制备工艺
CN117414341A (zh) * 2023-11-15 2024-01-19 南京正科医药股份有限公司 一种盐酸达泊西汀片及其制备方法
WO2024109829A1 (zh) * 2022-11-23 2024-05-30 中国科学院深圳先进技术研究院 抑制交感神经的医疗器械及其制备方法

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017507165A (ja) 2013-12-16 2017-03-16 マサチューセッツ インスティテュート オブ テクノロジー マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
WO2016204026A1 (ja) * 2015-06-15 2016-12-22 ｓｅｖｅｎ ｄｒｅａｍｅｒｓ ｌａｂｏｒａｔｏｒｉｅｓ株式会社 鼻腔留置デバイス
CA3066437A1 (en) * 2017-06-13 2018-12-20 EyePoint Pharmaceuticals, Inc. Bioerodible drug delivery devices
US20190076631A1 (en) * 2017-09-13 2019-03-14 Massachusetts Institute Of Technology Microdevices with complex geometries
CN109001188B (zh) * 2018-08-12 2021-09-14 河北农业大学 一种金刚烷胺和金刚乙胺的特异性分子印迹聚合物、化学发光试剂盒、检测方法及应用
CN114401716A (zh) * 2019-07-22 2022-04-26 纳诺米有限公司 持续释放的曲前列环素-化合物微粒组合物
CA3158651A1 (en) * 2019-11-27 2021-06-03 Marc M. Baum Permeable skin sustained release drug delivery device
JP7876831B2 (ja) 2021-02-26 2026-06-22 ナノ ターゲティング アンド セラピー バイオファーマ インコーポレイテッド 薬剤を後眼部に送達するための方法およびその使用
US12390420B1 (en) 2024-10-22 2025-08-19 Bryet Us, Inc. Compositions for targeted delivery of therapeutic agents and methods for the synthesis and use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1438873A (zh) * 2000-04-26 2003-08-27 控制递送系统有限公司 可持续释放药物的输送装置及其使用方法和制造方法
EP1140027B1 (en) * 1998-12-23 2005-10-12 Alza Corporation Dosage forms comprising porous particles
WO2012061377A1 (en) * 2010-11-01 2012-05-10 Psivida Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
US20120238993A1 (en) * 2010-12-22 2012-09-20 Martin Nazzaro Two-piece injectable drug delivery device with heat-cured seal

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3214667C2 (de) * 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
GB9815819D0 (en) * 1998-07-22 1998-09-16 Secr Defence Transferring materials into cells and a microneedle array
GB0104383D0 (en) * 2001-02-22 2001-04-11 Psimedica Ltd Cancer Treatment
CA2460334A1 (en) * 2001-09-14 2003-03-27 Francis J. Martin Microfabricated nanopore device for sustained release of therapeutic agent
US20100196435A1 (en) * 2007-07-10 2010-08-05 The Regents Of The University Of California Materials and methods for delivering compositions to selected tissues
WO2010111627A1 (en) * 2009-03-26 2010-09-30 Psivida Us, Inc. Implantable formulations of bisphosphonic acids
US20110238036A1 (en) * 2009-12-23 2011-09-29 Psivida Us, Inc. Sustained release delivery devices
AU2012214146A1 (en) * 2011-02-11 2013-08-29 Psivida Us, Inc. Methods of treating macular edema using antiedema therapeutics
US20130053794A1 (en) * 2011-08-29 2013-02-28 Suzanne Cadden Sustained release delivery of active agents to treat glaucoma and ocular hypertension

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140027B1 (en) * 1998-12-23 2005-10-12 Alza Corporation Dosage forms comprising porous particles
CN1438873A (zh) * 2000-04-26 2003-08-27 控制递送系统有限公司 可持续释放药物的输送装置及其使用方法和制造方法
WO2012061377A1 (en) * 2010-11-01 2012-05-10 Psivida Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
US20120238993A1 (en) * 2010-12-22 2012-09-20 Martin Nazzaro Two-piece injectable drug delivery device with heat-cured seal

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112137984A (zh) * 2020-10-30 2020-12-29 四川制药制剂有限公司 头孢克洛胶囊及其制备工艺
CN112137984B (zh) * 2020-10-30 2023-02-03 四川制药制剂有限公司 头孢克洛胶囊及其制备工艺
WO2024109829A1 (zh) * 2022-11-23 2024-05-30 中国科学院深圳先进技术研究院 抑制交感神经的医疗器械及其制备方法
CN117414341A (zh) * 2023-11-15 2024-01-19 南京正科医药股份有限公司 一种盐酸达泊西汀片及其制备方法

Also Published As

Publication number Publication date
RU2695536C2 (ru) 2019-07-23
US20140309610A1 (en) 2014-10-16
EP2968882A1 (en) 2016-01-20
WO2014165097A1 (en) 2014-10-09
AU2014248707B2 (en) 2018-11-22
RU2015132216A (ru) 2017-04-18
EP2968882B1 (en) 2021-05-19
CA2904204A1 (en) 2014-10-09
AU2014248707A1 (en) 2015-08-20
JP2016519654A (ja) 2016-07-07
JP6568513B2 (ja) 2019-08-28
HK1216864A1 (zh) 2016-12-09
EP2968882A4 (en) 2016-08-10

Similar Documents

Publication Publication Date Title
JP6568513B2 (ja) シリコン系担体粒子を含む薬物送達デバイス
US20120238993A1 (en) Two-piece injectable drug delivery device with heat-cured seal
US8871241B2 (en) Injectable sustained release delivery devices
US20110238036A1 (en) Sustained release delivery devices
JP5918195B2 (ja) 生物浸食性マトリクスコア及び生物浸食性スキンを有する注射可能な持続的放出用の送達用デバイス
TWI377958B (en) In-situ gelling drug delivery system
Sowjanya et al. Polymers used in the designing of controlled drug delivery system
DK2233112T3 (en) An injectable depot implant having a bioerodible matrix core and an outer membrane bioerodible

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1216864

Country of ref document: HK

CB02 Change of applicant information

Address after: Massachusetts, USA

Applicant after: Viewpoint Pharmaceutical USA Ltd.

Applicant after: pSiMedica Ltd.

Address before: Massachusetts, USA

Applicant before: Control Delivery Systems Inc.

Applicant before: pSiMedica Ltd.

CB02 Change of applicant information
RJ01 Rejection of invention patent application after publication

Application publication date: 20151104

RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1216864

Country of ref document: HK